CenterBook Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Sell |
13,467
-54,832
| -80% | -$6.23M | 0.09% | 265 |
|
|
2025
Q1 | $7.18M | Buy |
68,299
+44,760
| +190% | +$4.71M | 0.46% | 58 |
|
|
2024
Q4 | $2.52M | Sell |
23,539
-27,437
| -54% | -$2.94M | 0.15% | 171 |
|
|
2024
Q3 | $5.1M | Sell |
50,976
-2,403
| -5% | -$241K | 0.31% | 94 |
|
|
2024
Q2 | $4.5M | Buy |
53,379
+20,749
| +64% | +$1.75M | 0.28% | 132 |
|
|
2024
Q1 | $2.39M | Buy |
+32,630
| New | +$2.39M | 0.16% | 214 |
|